Evrysdi 5 mg – DIN 02560747
Evrysdi is Risdiplam 5 mg (tablet), sold in Canada. It is used for spinal muscular atrophy. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Risdiplam 5 mg
- Brand
- Evrysdi
- Strength
- 5 mg
- Used for
- Spinal muscular atrophy
- Form
- Tablet
- Manufacturer
- Hoffmann-LA Roche Limited
- Drug class
- Survival of motor neuron 2 splicing modifier
- Sold in
- Canada
- DIN
- 02560747
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Risdiplam used for?
Risdiplam is used for spinal muscular atrophy.
- Medicine type
- Survival of motor neuron 2 splicing modifier
Official uses from the US prescribing label
EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
From the FDA-approved label on DailyMed (published Sep 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02560747.
- It names Evrysdi, Risdiplam 5 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Evrysdi by Hoffmann-LA Roche Limited.
In Canada: prescription only.
Ingredients
Active: Risdiplam